Victory Capital Management Portfolio holdings
AUM
$155B
1-Year Return
20.6%
This Quarter Return
-0.22%
1 Year Return
+20.6%
3 Year Return
+77.5%
5 Year Return
+161.59%
10 Year Return
+412.71%
AUM
$102B
AUM Growth
-$2.04B
(-2%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
10.73%
Holding
2,911
New
181
Increased
1,145
Reduced
1,360
Closed
133
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$195M |
| 2 |
Newell Brands
NWL
|
+$186M |
| 3 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$146M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$131M |
| 5 |
Westlake Corp
WLK
|
+$104M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$235M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$235M |
| 3 |
AutoNation
AN
|
+$189M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$175M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$132M |
Sector Composition
| 1 | Technology | 17.67% |
| 2 | Industrials | 13.82% |
| 3 | Financials | 12.32% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Healthcare | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Immunocore
IMCR
$1.84B
| $353K | ﹤0.01% |
9,528
| – | – |
|
2302
Republic Bancorp
RBCAA
$1.51B
| $351K | ﹤0.01% |
+6,921
| New | +$351K |
|
|
SHCR
2303
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $350K | ﹤0.01% |
+42,567
| New | +$350K |
|
2304
Cytokinetics
CYTK
$6.38B
| $349K | ﹤0.01% |
+9,771
| New | +$349K |
|
2305
GATX Corp
GATX
$6.11B
| $348K | ﹤0.01% |
3,888
-129
| -3% | -$11.5K |
|
2306
Huron Consulting
HURN
$2.46B
| $348K | ﹤0.01% |
+6,699
| New | +$348K |
|
2307
Team
TISI
$81.4M
| $347K | ﹤0.01% |
11,520
+70
| +0.6% | +$2.11K |
|
2308
Artisan Partners
APAM
$3.32B
| $346K | ﹤0.01% |
7,072
-314
| -4% | -$15.4K |
|
2309
Cadence Bank
CADE
$6.96B
| $344K | ﹤0.01% |
11,546
-421
| -4% | -$12.5K |
|
2310
Leslie's
LESL
$62.2M
| $344K | ﹤0.01% |
16,755
+2,838
| +20% | +$58.3K |
|
2311
Liberty Latin America Class C
LILAK
$1.55B
| $344K | ﹤0.01% |
+26,195
| New | +$344K |
|
2312
Tootsie Roll Industries
TR
$2.91B
| $344K | ﹤0.01% |
12,717
-560
| -4% | -$15.1K |
|
|
BRSP
2313
BrightSpire Capital
BRSP
$772M
| $342K | ﹤0.01% |
36,432
-288
| -0.8% | -$2.7K |
|
2314
Helmerich & Payne
HP
$2.08B
| $342K | ﹤0.01% |
12,463
-1,138
| -8% | -$31.2K |
|
2315
LivaNova
LIVN
$3.13B
| $342K | ﹤0.01% |
+4,322
| New | +$342K |
|
2316
El Pollo Loco
LOCO
$313M
| $341K | ﹤0.01% |
20,148
+3,975
| +25% | +$67.3K |
|
2317
IDT Corp
IDT
$1.65B
| $335K | ﹤0.01% |
7,996
-2,740
| -26% | -$115K |
|
2318
Allogene Therapeutics
ALLO
$260M
| $334K | ﹤0.01% |
13,010
-47,258
| -78% | -$1.21M |
|
2319
Gold Resource Corp
GORO
$114M
| $334K | ﹤0.01% |
212,498
-530
| -0.2% | -$833 |
|
2320
Vicor
VICR
$2.29B
| $334K | ﹤0.01% |
2,486
-120
| -5% | -$16.1K |
|
2321
Vornado Realty Trust
VNO
$8.07B
| $333K | ﹤0.01% |
7,934
-66
| -0.8% | -$2.77K |
|
2322
Babcock & Wilcox
BW
$250M
| $332K | ﹤0.01% |
+51,858
| New | +$332K |
|
2323
4D Molecular Therapeutics
FDMT
$330M
| $331K | ﹤0.01% |
12,259
-131
| -1% | -$3.54K |
|
2324
National Beverage
FIZZ
$3.78B
| $330K | ﹤0.01% |
6,281
-4,664
| -43% | -$245K |
|
2325
Zentalis Pharmaceuticals
ZNTL
$113M
| $329K | ﹤0.01% |
4,934
+898
| +22% | +$59.9K |
|